Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Pestrin

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Pathology|June 21, 2007
Markers of the uPA system and common prognostic factors in breast cancerAlessandro Marco Minisini, Dora Fabbro, Carla Di Loreto, et al.
Breast Cancer Research and Treatment|July 15, 2009
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patientsMarta Pestrin, Silvia Bessi, Francesca Galardi, et al.
Anticancer Research|August 1, 2018
Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the LiteratureLorenzo Rossi, Chiara Biagioni, Amelia McCartney, et al.
Plos One|May 14, 2013
The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept studyJustin Stebbing, Rachel Payne, Justine Reise, et al.
Oncotarget|April 2, 2016
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancerFrancesca De Luca, Giada Rotunno, Francesca Salvianti, et al.
Oncotarget|April 18, 2018
Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapyMartina Bonechi, Francesca Galardi, Chiara Biagioni, et al.
NPJ Breast Cancer|March 8, 2025
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancerRiccardo Scandino, Agostina Nardone, Nicola Casiraghi, et al.
Briefings in Bioinformatics|January 18, 2023
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samplesDario Romagnoli, Agostina Nardone, Francesca Galardi, et al.
Critical Reviews in Oncology/Hematology|October 18, 2022
Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approachCaterina Fontanella, Carlo Alberto Giorgi, Stefania Russo, et al.
Genome Medicine|February 4, 2026
A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencingMarta Paoli, Francesca Galardi, Agostina Nardone, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Pathology|June 21, 2007
Markers of the uPA system and common prognostic factors in breast cancerAlessandro Marco Minisini, Dora Fabbro, Carla Di Loreto, et al.
Breast Cancer Research and Treatment|July 15, 2009
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patientsMarta Pestrin, Silvia Bessi, Francesca Galardi, et al.
Anticancer Research|August 1, 2018
Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the LiteratureLorenzo Rossi, Chiara Biagioni, Amelia McCartney, et al.
Plos One|May 14, 2013
The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept studyJustin Stebbing, Rachel Payne, Justine Reise, et al.
Oncotarget|April 2, 2016
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancerFrancesca De Luca, Giada Rotunno, Francesca Salvianti, et al.
Oncotarget|April 18, 2018
Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapyMartina Bonechi, Francesca Galardi, Chiara Biagioni, et al.
NPJ Breast Cancer|March 8, 2025
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancerRiccardo Scandino, Agostina Nardone, Nicola Casiraghi, et al.
Briefings in Bioinformatics|January 18, 2023
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samplesDario Romagnoli, Agostina Nardone, Francesca Galardi, et al.
Critical Reviews in Oncology/Hematology|October 18, 2022
Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approachCaterina Fontanella, Carlo Alberto Giorgi, Stefania Russo, et al.
Genome Medicine|February 4, 2026
A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencingMarta Paoli, Francesca Galardi, Agostina Nardone, et al.
Pageof 4